[Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
The cases previously described with tranylcipromine and phenelzine abuse have been reviewed and the main epidemiological, clinical and diagnostic characteristics of them have been analyzed. The aim is to obtain a profile of the patients at risk to develop this kind of problem. In addition, several important questions and the most accepted pharmacological bases of this drugs' addiction are revised.